FIELD: medicine.
SUBSTANCE: pharmaceutical composition containing sodium metaarsenite (NaAsO2) in a therapeutically effective amount to reduce pain not associated with cancer in a mammal, and its use in the manufacture of a pharmaceutical composition are proposed.
EFFECT: combination of safety benefits, long time staying in blood and wide distribution in tissues.
18 cl, 1 tbl, 12 dwg
Authors
Dates
2017-09-11—Published
2008-02-01—Filed